Calidi Biotherapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Calidi Biotherapeutics Inc
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
Frequently asked questions
To buy Calidi Biotherapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Calidi Biotherapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Calidi Biotherapeutics Inc is CLDI:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Calidi Biotherapeutics Inc has its primary listing on NYSE American. You can trade Calidi Biotherapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Calidi Biotherapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Calidi Biotherapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Calidi Biotherapeutics Inc.